138 related articles for article (PubMed ID: 31668922)
21. Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry.
Cayabyab M; Hinuma S; Farzan M; Choe H; Fukusumi S; Kitada C; Nishizawa N; Hosoya M; Nishimura O; Messele T; Pollakis G; Goudsmit J; Fujino M; Sodroski J
J Virol; 2000 Dec; 74(24):11972-6. PubMed ID: 11090199
[TBL] [Abstract][Full Text] [Related]
22. GPCR-Gα protein precoupling: Interaction between Ste2p, a yeast GPCR, and Gpa1p, its Gα protein, is formed before ligand binding via the Ste2p C-terminal domain and the Gpa1p N-terminal domain.
Cevheroğlu O; Becker JM; Son ÇD
Biochim Biophys Acta Biomembr; 2017 Dec; 1859(12):2435-2446. PubMed ID: 28958779
[TBL] [Abstract][Full Text] [Related]
23. The apelin/APJ system as a therapeutic target in metabolic diseases.
Castan-Laurell I; Masri B; Valet P
Expert Opin Ther Targets; 2019 Mar; 23(3):215-225. PubMed ID: 30570369
[TBL] [Abstract][Full Text] [Related]
24. The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis.
O'Carroll AM; Lolait SJ; Harris LE; Pope GR
J Endocrinol; 2013 Oct; 219(1):R13-35. PubMed ID: 23943882
[TBL] [Abstract][Full Text] [Related]
25. Heterodimerization of mouse orexin type 2 receptor variants and the effects on signal transduction.
Wang C; Pan Y; Zhang R; Bai B; Chen J; Randeva HS
Biochim Biophys Acta; 2014 Mar; 1843(3):652-63. PubMed ID: 24368186
[TBL] [Abstract][Full Text] [Related]
26. Novel pathogenesis: regulation of apoptosis by Apelin/APJ system.
Liu J; Liu M; Chen L
Acta Biochim Biophys Sin (Shanghai); 2017 Jun; 49(6):471-478. PubMed ID: 28407045
[TBL] [Abstract][Full Text] [Related]
27. The mechanosensitive APJ internalization via clathrin-mediated endocytosis: A new molecular mechanism of cardiac hypertrophy.
He L; Chen L; Li L
Med Hypotheses; 2016 May; 90():6-10. PubMed ID: 27063076
[TBL] [Abstract][Full Text] [Related]
28. Apelin/APJ system: A novel promising target for anti-aging intervention.
Zhou Q; Chen L; Tang M; Guo Y; Li L
Clin Chim Acta; 2018 Dec; 487():233-240. PubMed ID: 30296443
[TBL] [Abstract][Full Text] [Related]
29. Molecular determinants on extracellular loop domains that dictate interaction between β-arrestin and human APJ receptor.
Ashokan A; Kameswaran M; Aradhyam GK
FEBS Lett; 2019 Mar; 593(6):634-643. PubMed ID: 30801688
[TBL] [Abstract][Full Text] [Related]
30. Apelin and Elabela/Toddler; double ligands for APJ/Apelin receptor in heart development, physiology, and pathology.
Kuba K; Sato T; Imai Y; Yamaguchi T
Peptides; 2019 Jan; 111():62-70. PubMed ID: 29684595
[TBL] [Abstract][Full Text] [Related]
31. Discovery of a novel small molecule agonist scaffold for the APJ receptor.
Narayanan S; Maitra R; Deschamps JR; Bortoff K; Thomas JB; Zhang Y; Warner K; Vasukuttan V; Decker A; Runyon SP
Bioorg Med Chem; 2016 Aug; 24(16):3758-70. PubMed ID: 27369451
[TBL] [Abstract][Full Text] [Related]
32. The apelin receptor influences biomechanical and morphological properties of endothelial cells.
Strohbach A; Pennewitz M; Glaubitz M; Palankar R; Groß S; Lorenz F; Materzok I; Rong A; Busch MC; Felix SB; Delcea M; Busch R
J Cell Physiol; 2018 Aug; 233(8):6250-6261. PubMed ID: 29369349
[TBL] [Abstract][Full Text] [Related]
33. The N-terminal domain of APJ, a CNS-based coreceptor for HIV-1, is essential for its receptor function and coreceptor activity.
Zhou N; Zhang X; Fan X; Argyris E; Fang J; Acheampong E; DuBois GC; Pomerantz RJ
Virology; 2003 Dec; 317(1):84-94. PubMed ID: 14675627
[TBL] [Abstract][Full Text] [Related]
34. Apelin/APJ system: A potential therapeutic target for endothelial dysfunction-related diseases.
Cheng J; Luo X; Huang Z; Chen L
J Cell Physiol; 2019 Aug; 234(8):12149-12160. PubMed ID: 30585633
[TBL] [Abstract][Full Text] [Related]
35. Emerging roles of apelin in biology and medicine.
Kleinz MJ; Davenport AP
Pharmacol Ther; 2005 Aug; 107(2):198-211. PubMed ID: 15907343
[TBL] [Abstract][Full Text] [Related]
36. A hallmark of immunoreceptor, the tyrosine-based inhibitory motif ITIM, is present in the G protein-coupled receptor OX1R for orexins and drives apoptosis: a novel mechanism.
Voisin T; El Firar A; Rouyer-Fessard C; Gratio V; Laburthe M
FASEB J; 2008 Jun; 22(6):1993-2002. PubMed ID: 18198212
[TBL] [Abstract][Full Text] [Related]
37. Non-activated APJ suppresses the angiotensin II type 1 receptor, whereas apelin-activated APJ acts conversely.
Sun X; Iida S; Yoshikawa A; Senbonmatsu R; Imanaka K; Maruyama K; Nishimura S; Inagami T; Senbonmatsu T
Hypertens Res; 2011 Jun; 34(6):701-6. PubMed ID: 21412239
[TBL] [Abstract][Full Text] [Related]
38. Discovery of a functional immunoreceptor tyrosine-based switch motif in a 7-transmembrane-spanning receptor: role in the orexin receptor OX1R-driven apoptosis.
El Firar A; Voisin T; Rouyer-Fessard C; Ostuni MA; Couvineau A; Laburthe M
FASEB J; 2009 Dec; 23(12):4069-80. PubMed ID: 19661287
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin.
Medhurst AD; Jennings CA; Robbins MJ; Davis RP; Ellis C; Winborn KY; Lawrie KW; Hervieu G; Riley G; Bolaky JE; Herrity NC; Murdock P; Darker JG
J Neurochem; 2003 Mar; 84(5):1162-72. PubMed ID: 12603839
[TBL] [Abstract][Full Text] [Related]
40. Targeting drugs to APJ receptor: From signaling to pathophysiological effects.
Huang Z; He L; Chen Z; Chen L
J Cell Physiol; 2018 Jan; 234(1):61-74. PubMed ID: 30070701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
